Contract Research Organization Services (CROs) Market by Type (Discovery, CMC, Preclinical, Clinical Research, Laboratory Services), Therapeutic Area (Oncology, CNS, Cardiovascular), End User (Pharmaceuticals & Medical Device) - Global Forecast to 2023

Contract research organizations (CROs) offer testing and consulting services for every stage of the drug R&D process for commercial manufacturers such as pharmaceutical and biopharmaceutical companies and medical device firms. The CRO services market is valued at USD 36.27 Billion in 2017 and projected to reach to USD 56.34 Billion by 2023, at a CAGR of 7.6%. Base year considered for the report is 2017 and forecast period includes 2018–2023. Growing R&D expenditures, increased outsourcing of R&D activities, and increasing number of clinical trials are the major factors driving the growth of the CRO services market.

Objectives of the Study

• To define, describe, segment and forecast the global CRO services market by type, therapeutic area, end user, and region
• To forecast the size of the CRO services market with respect to the five key regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
• To provide detailed information regarding the major factors influencing the growth of the contract research organization services market (drivers, restraints, opportunities, and industry-specific challenges)
• To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze the opportunities in the contract research organization services market for stakeholders and provide details of the competitive landscape for market leaders
• To profile the key players in the global CRO services market and comprehensively analyze their core competencies
• To track and analyze competitive developments such as mergers and acquisitions; agreements, partnerships, and collaborations; service launches; and expansions of key players in the global CRO services market

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the global CRO services market and estimate the size of other dependent submarkets. Various secondary sources such as directories, industry journals, databases, and annual reports of the companies have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of contract research organization services market. The breakdown of profiles of primary research participants is shown in the figure below:

To know about the assumptions considered for the study, download the pdf brochure

IQVIA (US), LabCorp (US), Syneos Health (US), PAREXEL (US), PPD (US), ICON plc (Ireland), PRA Health Sciences (US), and Charles River (US) are some of the key players in the global CRO services market.

Target Audience

• Pharmaceutical and biopharmaceutical companies
• Contract research organizations (CROs)
• Medical device manufacturing companies
• Academic and research institutes
• Government associations
• Market research and consulting Firms
• Venture capitalists and investors

Scope of the Report

In this report, the CRO services market has been segmented into the following segments and subsegments:

CRO Services Market, by Type

• Early Phase Development Services
  • Discovery Studies
  • Chemistry, Manufacturing & Control
  • Preclinical Services
• Pharmacokinetics/Pharmacodynamics (PK/PD)
• Toxicology Testing
• Others
• Clinic Research Services
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
• Laboratory Services
  • Bioanalytical Testing
  • Analytical Testing
• Physical Characterization
• Stability Testing
• Batch Release Testing
• Raw Material Testing
• Other Analytical Testing
• Consulting Services

CRO Services Market, by Therapeutic Area

• Oncology
• CNS Disorders
• Infectious Diseases
• Cardiovascular Diseases
• Immunological Disorders
• Respiratory Disorders
• Diabetes
• Other Therapeutic Areas

CRO Services Market, by End User

• Pharmaceutical and Biopharmaceutical Companies
• Medical Device Companies
• Academic Institutes

CRO Services Market, by Region

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Rest of Asia Pacific
• Latin America
• Middle East and Africa

Available Customization:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographic Analysis

• Further breakdown of the Rest of Asia Pacific CRO services market into South Korea, Australia, New Zealand, and others
• Further breakdown of the Rest of Europe CRO services market into Belgium, Russia, Netherlands, Switzerland, and others
• Further breakdown of the Rest of Latin America CRO services market into Brazil, Argentina, and Mexico

Company Information

• Detailed analysis and profiling of additional market players (up to 5)

Table of Contents

1 Introduction (Page No. - 20)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 24)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
    2.2 Market Size Estimation
           2.2.1 Bottom-Up Approach
           2.2.2 Top-Down Approach
    2.3 Market Breakdown and Data Triangulation
    2.4 Market Share Estimation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 32)

4 Premium Insights (Page No. - 35)
    4.1 CRO Services Market Overview
    4.2 Asia Pacific: CRO Services Market, By Type and Country
    4.3 CRO Services Market: Geographic Growth Opportunities
    4.4 CRO Services Market: Geographic Mix
    4.5 CRO Services Market: Developing vs Developed Countries

5 Market Overview (Page No. - 40)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Growing R&D Expenditure
                    5.2.1.2 Increased Outsourcing of R&D Activities
                    5.2.1.3 Increasing Number of Clinical Trials
           5.2.2 Opportunities
                    5.2.2.1 Growth in the Biosimilars and Biologics Markets
                    5.2.2.2 Rising Demand for Specialized Testing Services
                    5.2.2.3 Emerging Asian Markets
           5.2.3 Challenges
                    5.2.3.1 Intense Competition in the CRO Services Market
                    5.2.3.2 Shortage of Skilled Professionals
    5.3 Industry Trends
           5.3.1 Growing Consolidation in the CRO Industry
           5.3.2 Increasing Outsourcing of Clinical Trials to Emerging Markets
           5.3.3 Adoption of New Technologies

6 CRO Services Market, By Type (Page No. - 52)
    6.1 Introduction
    6.2 Clinical Research Services
           6.2.1 Phase I Clinical Research Services
           6.2.2 Phase Ii Clinical Research Services
           6.2.3 Phase Iii Clinical Research Services
           6.2.4 Phase Iv Clinical Research Services
    6.3 Early-Phase Development Services
           6.3.1 Discovery Studies
           6.3.2 Chemistry, Manufacturing, & Control (CMC)
           6.3.3 Preclinical Services
                    6.3.3.1 Pharmacokinetics/Pharmacodynamics (PK/PD)
                    6.3.3.2 Toxicology Testing Services
                    6.3.3.3 Other Preclinical Services
    6.4 Laboratory Services
           6.4.1 Bioanalytical Testing Services
           6.4.2 Analytical Testing Services
                    6.4.2.1 Physical Characterization
                    6.4.2.2 Raw Material Testing
                    6.4.2.3 Batch-Release Testing
                    6.4.2.4 Stability Testing
                    6.4.2.5 Other Analytical Testing Services
    6.5 Consulting Services

7 Global CRO Services Market, By Therapeutic Area (Page No. - 85)
    7.1 Introduction
    7.2 Oncology
    7.3 Infectious Diseases
    7.4 Central Nervous System (CNS) Disorders
    7.5 Immunological Disorders
    7.6 Cardiovascular Diseases
    7.7 Respiratory Disorders
    7.8 Diabetes
    7.9 Other Therapeutic Areas

8 CRO Services Market, By End User (Page No. - 104)
    8.1 Introduction
    8.2 Pharmaceutical & Biopharmaceutical Companies
    8.3 Medical Device Companies
    8.4 Academic Institutes

9 CRO Services Market, By Region (Page No. - 111)
    9.1 Introduction
    9.2 North America
           9.2.1 US
           9.2.2 Canada
    9.3 Europe
           9.3.1 Germany
           9.3.2 UK
           9.3.3 France
           9.3.4 Italy
           9.3.5 Spain
           9.3.6 Rest of Europe
    9.4 Asia Pacific
           9.4.1 China
           9.4.2 Japan
           9.4.3 India
           9.4.4 Rest of Asia Pacific
    9.5 Latin America
    9.6 Middle East & Africa

10 Competitive Landscape (Page No. - 190)
     10.1 Overview
     10.2 Market Share Analysis
     10.3 Competitive Scenario
             10.3.1 Agreements, Collaborations, Joint Ventures, and Partnerships (2014-2017)
             10.3.2 Service Launches (2014-2017)
             10.3.3 Expansions (2014-2017)
             10.3.4 Acquisitions (2014-2017)

11 Company Profiles (Page No. - 197)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
     11.1 IQVIA
     11.2 LabCorp
     11.3 PAREXEL
     11.4 PRA Health Sciences
     11.5 PPD
     11.6 ICON PLC 
     11.7 Syneos Health
     11.8 WuXi Pharmatech
     11.9 Charles River
     11.10 MeDPAce Holdings
     11.11 SGS
     11.12 Envigo
     11.13 MPI Research

*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 249)
     12.1 Insights of Industry Experts
     12.2 Discussion Guide
     12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.4 Introducing RT: Real-Time Market Intelligence
     12.5 Available Customizations
     12.6 Related Reports
     12.7 Author Details

List of Tables (220 Tables)

Table 1 Exchange Rates Utilized for the Conversion to USD
Table 2 R&D Expenditure & Percentage Change, By Pharmaceutical Company (2014–2016)
Table 3 Increased Outsourcing of R&D Activities to Drive Market Growth
Table 4 List of Biological License Application Approvals in the US, 2016
Table 5 Clinical Studies for Biologic & Biosimilar Molecules (2017)
Table 6 Growing Biosimilars and Biologics Markets to Provide Significant Growth Opportunities
Table 7 Intense Competition in the CRO Services Market is A Major Challenge in the Market
Table 8 Major Mergers and Acquisitions in CRO Industry (2013-2017)
Table 9 CRO Services Market, By Type, 2016–2023 (USD Million)
Table 10 CRO Services Market, By Country, 2016–2023 (USD Million)
Table 11 Number of Registered and Recruiting Clinical Studies, By Location, 2017
Table 12 Key Clinical Research Services Offered By Prominent Players
Table 13 Clinical Research Services Market, By Type, 2016–2023 (USD Million)
Table 14 Clinical Research Services Market, By Country, 2016–2023 (USD Million)
Table 15 Completed Phase Ii Studies for Different Therapeutic Areas
Table 16 Phase I Clinical Research Services Market, By Country, 2016–2023 (USD Million)
Table 17 Completed Phase Ii Studies for Different Therapeutic Areas
Table 18 Phase Ii Clinical Research Services Market, By Country, 2016–2023 (USD Million)
Table 19 Completed Phase Iii Studies for Different Therapeutic Areas
Table 20 Phase Iii Clinical Research Services Market, By Country, 2016–2023 (USD Million)
Table 21 Completed Phase Iv Studies for Different Therapeutic Areas
Table 22 Phase Iv Clinical Research Services Market, By Country, 2016–2023 (USD Million)
Table 23 Key Early-Phase Development Services Offered By Prominent Players
Table 24 Early-Phase Development Services Market, By Type, 2016–2023 (USD Million)
Table 25 Early-Phase Development Services Market, By Country, 2016–2023 (USD Million)
Table 26 Discovery Studies Market, By Country, 2016–2023 (USD Million)
Table 27 Chemistry, Manufacturing, & Control Market, By Country, 2016–2023 (USD Million)
Table 28 Preclinical Services Market, By Type, 2016–2023 (USD Million)
Table 29 Preclinical Services Market, By Country, 2016–2023 (USD Million)
Table 30 Pharmacokinetics/Pharmacodynamics Market, By Country, 2016–2023 (USD Million)
Table 31 Toxicology Testing Services Market, By Country, 2016–2023 (USD Million)
Table 32 Other Preclinical Services Market, By Country, 2016–2023 (USD Million)
Table 33 Laboratory Services: Key Services Offered By Prominent Players
Table 34 Laboratory Services Market, By Type, 2016–2023 (USD Million)
Table 35 Laboratory Services Market, By Country, 2016–2023 (USD Million)
Table 36 Bioanalytical Testing Services Market, By Country, 2016–2023 (USD Million)
Table 37 Analytical Testing Services Market, By Type, 2016–2023 (USD Million)
Table 38 Analytical Testing Services Market, By Country, 2016–2023 (USD Million)
Table 39 Physical Characterization Services Market, By Country, 2016–2023 (USD Million)
Table 40 Raw Material Testing Services Market, By Country, 2016–2023 (USD Million)
Table 41 Batch-Release Testing Services Market, By Country, 2016–2023 (USD Million)
Table 42 Stability Testing Services Market, By Country, 2016–2023 (USD Million)
Table 43 Other Analytical Testing Services Market, By Country, 2016–2023 (USD Million)
Table 44 Consulting Services: Key Services Offered By Prominent Players
Table 45 Consulting Services Market, By Country, 2016–2023 (USD Million)
Table 46 Global Number of Clinical Trials in Different Therapeutic Areas, 2017
Table 47 CRO Services Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 48 CRO Services Market for Oncology, By Country, 2016–2023 (USD Million)
Table 49 List of Pipeline Drugs for Infectious Diseases (2016)
Table 50 CRO Services Market for Infectious Diseases, By Country, 2016–2023 (USD Million)
Table 51 List of Pipeline Drugs for CNS Disorders (2016)
Table 52 CRO Services Market for CNS Disorders, By Country, 2016–2023 (USD Million)
Table 53 Prevalence of Pid, By Region, 2013 vs 2015
Table 54 List of Pipeline Drugs for Immunological Disorders (2016)
Table 55 CRO Services Market for Immunological Disorders, By Country, 2016–2023 (USD Million)
Table 56 List of Pipeline Drugs for Cardiovascular Diseases (2016)
Table 57 CRO Services Market for Cardiovascular Diseases, By Country, 2016–2023 (USD Million)
Table 58 List of Pipeline Drugs for Respiratory Disorders (2016)
Table 59 CRO Services Market for Respiratory Disorders, By Country, 2016–2023 (USD Million)
Table 60 List of Pipeline Drugs for Diabetes (2016)
Table 61 CRO Services Market for Diabetes, By Country, 2016–2023 (USD Million)
Table 62 List of Pipeline Drugs for Other Therapeutic Areas (2016)
Table 63 CRO Services Market for Other Therapeutic Areas, By Country/Region, 2016–2023 (USD Million)
Table 64 CRO Services Market, By End User, 2016–2023 (USD Million)
Table 65 Number of Biopharmaceutical Drugs in Development Across the Globe, 2016
Table 66 CRO Services Market for Pharmaceutical and Biopharmaceutical Companies, By Country, 2016–2023 (USD Million)
Table 67 CRO Services Market for Medical Device Companies, By Country, 2016–2023 (USD Million)
Table 68 CRO Services Market for Academic Institutes, By Country, 2016–2023 (USD Million)
Table 69 CRO Services Market, By Region, 2016–2023 (USD Million)
Table 70 North America: CRO Services Market, By Country, 2016–2023 (USD Million)
Table 71 North America: CRO Services Market, By Type, 2016–2023 (USD Million)
Table 72 North America: Early-Phase Development Services Market, By Type, 2016–2023 (USD Million)
Table 73 North America: Preclinical Services Market, By Type, 2016–2023 (USD Million)
Table 74 North America: Clinical Research Services Market, By Type, 2016–2023 (USD Million)
Table 75 North America: Laboratory Services Market, By Type, 2016–2023 (USD Million)
Table 76 North America: Analytical Testing Services Market, By Type, 2016–2023 (USD Million)
Table 77 North America: CRO Services Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 78 North America: CRO Services Market, By End User, 2016–2023 (USD Million)
Table 79 Total Number of Clinical Trials in the US (2017)
Table 80 US: CRO Services Market, By Type, 2016–2023 (USD Million)
Table 81 US: Early-Phase Development Services Market, By Type, 2016–2023 (USD Million)
Table 82 US: Preclinical Services Market, By Type, 2016–2023 (USD Million)
Table 83 US: Clinical Research Services Market, By Type, 2016–2023 (USD Million)
Table 84 US: Laboratory Services Market, By Type, 2016–2023 (USD Million)
Table 85 US: Analytical Testing Services Market, By Type, 2016–2023 (USD Million)
Table 86 US: CRO Services Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 87 US: CRO Services Market, By End User, 2016–2023 (USD Million)
Table 88 Canada: CRO Services Market, By Type, 2016–2023 (USD Million)
Table 89 Canada: Early-Phase Development Services Market, By Type, 2016–2023 (USD Million)
Table 90 Canada: Preclinical Services Market, By Type, 2016–2023 (USD Million)
Table 91 Canada: Clinical Research Services Market, By Type, 2016–2023 (USD Million)
Table 92 Canada: Laboratory Services Market, By Type, 2016–2023 (USD Million)
Table 93 Canada: Analytical Testing Services Market, By Type, 2016–2023 (USD Million)
Table 94 Canada: CRO Services Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 95 Canada: CRO Services Market, By End User, 2016–2023 (USD Million)
Table 96 Europe: Pharmaceutical R&D Expenditure, By Country, 2012 vs 2014
Table 97 Europe: CRO Services Market, By Country, 2016–2023 (USD Million)
Table 98 Europe: CRO Services Market, By Type, 2016–2023 (USD Million)
Table 99 Europe: Early-Phase Development Services Market, By Type, 2016–2023 (USD Million)
Table 100 Europe: Preclinical Services Market, By Type, 2016–2023 (USD Million)
Table 101 Europe: Clinical Research Services Market, By Type, 2016–2023 (USD Million)
Table 102 Europe: Laboratory Services Market, By Type, 2016–2023 (USD Million)
Table 103 Europe: Analytical Testing Services Market, By Type, 2016–2023 (USD Million)
Table 104 Europe: CRO Services Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 105 Europe: CRO Services Market, By End User, 2016–2023 (USD Million)
Table 106 Germany: CRO Services Market, By Type, 2016–2023 (USD Million)
Table 107 Germany: Early-Phase Development Services Market, By Type, 2016–2023 (USD Million)
Table 108 Germany: Preclinical Services Market, By Type, 2016–2023 (USD Million)
Table 109 Germany: Clinical Research Services Market, By Type, 2016–2023 (USD Million)
Table 110 Germany: Laboratory Services Market, By Type, 2016–2023 (USD Million)
Table 111 Germany: Analytical Testing Services Market, By Type, 2016–2023 (USD Million)
Table 112 Germany: CRO Services Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 113 Germany: CRO Services Market, By End User, 2016–2023 (USD Million)
Table 114 UK: CRO Services Market, By Type, 2016–2023 (USD Million)
Table 115 UK: Early-Phase Development Services Market, By Type, 2016–2023 (USD Million)
Table 116 UK: Preclinical Services Market, By Type, 2016–2023 (USD Million)
Table 117 UK: Clinical Research Services Market, By Type, 2016–2023 (USD Million)
Table 118 UK: Laboratory Services Market, By Type, 2016–2023 (USD Million)
Table 119 UK: Analytical Testing Services Market, By Type, 2016–2023 (USD Million)
Table 120 UK: CRO Services Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 121 UK: CRO Services Market, By End User, 2016–2023 (USD Million)
Table 122 France: CRO Services Market, By Type, 2016–2023 (USD Million)
Table 123 France: Early-Phase Development Services Market, By Type, 2016–2023 (USD Million)
Table 124 France: Preclinical Services Market, By Type, 2016–2023 (USD Million)
Table 125 France: Clinical Research Services Market, By Type, 2016–2023 (USD Million)
Table 126 France: Laboratory Services Market, By Type, 2016–2023 (USD Million)
Table 127 France: Analytical Testing Services Market, By Type, 2016–2023 (USD Million)
Table 128 France: CRO Services Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 129 France: CRO Services Market, By End User, 2016–2023 (USD Million)
Table 130 Clinical Trials in Italy (2013 vs 2014)
Table 131 Italy: CRO Services Market, By Type, 2016–2023 (USD Million)
Table 132 Italy: Early-Phase Development Services Market, By Type, 2016–2023 (USD Million)
Table 133 Italy: Preclinical Services Market, By Type, 2016–2023 (USD Million)
Table 134 Italy: Clinical Research Services Market, By Type, 2016–2023 (USD Million)
Table 135 Italy: Laboratory Services Market, By Type, 2016–2023 (USD Million)
Table 136 Italy: Analytical Testing Services Market, By Type, 2016–2023 (USD Million)
Table 137 Italy: CRO Services Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 138 Italy: CRO Services Market, By End User, 2016–2023 (USD Million)
Table 139 Spain: CRO Services Market, By Type, 2016–2023 (USD Million)
Table 140 Spain: Early-Phase Development Services Market, By Type, 2016–2023 (USD Million)
Table 141 Spain: Preclinical Services Market, By Type, 2016–2023 (USD Million)
Table 142 Spain: Clinical Research Services Market, By Type, 2016–2023 (USD Million)
Table 143 Spain: Laboratory Services Market, By Type, 2016–2023 (USD Million)
Table 144 Spain: Analytical Testing Services Market, By Type, 2016–2023 (USD Million)
Table 145 Spain: CRO Services Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 146 Spain: CRO Services Market, By End User, 2016–2023 (USD Million)
Table 147 Pharmaceutical R&D Expenditure & Production in RoE Countries (2012 vs 2014)
Table 148 RoE: CRO Services Market, By Type, 2016–2023 (USD Million)
Table 149 RoE: Early-Phase Development Services Market, By Type, 2016–2023 (USD Million)
Table 150 RoE: Preclinical Services Market, By Type, 2016–2023 (USD Million)
Table 151 RoE: Clinical Research Services Market, By Type, 2016–2023 (USD Million)
Table 152 RoE: Laboratory Services Market, By Type, 2016–2023 (USD Million)
Table 153 RoE: Analytical Testing Services Market, By Type, 2016–2023 (USD Million)
Table 154 RoE: CRO Services Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 155 RoE: CRO Services Market, By End User, 2016–2023 (USD Million)
Table 156 Total Number of Clinical Trials in Asia Pacific, By Therapeutic Area, 2017
Table 157 Asia Pacific: CRO Services Market, By Country, 2016–2023 (USD Million)
Table 158 Asia Pacific: CRO Services Market, By Type, 2016–2023 (USD Million)
Table 159 Asia Pacific: Early-Phase Development Services Market, By Type, 2016–2023 (USD Million)
Table 160 Asia Pacific: Preclinical Services Market, By Type, 2016–2023 (USD Million)
Table 161 Asia Pacific: Clinical Research Services Market, By Type, 2016–2023 (USD Million)
Table 162 Asia Pacific: Laboratory Services Market, By Type, 2016–2023 (USD Million)
Table 163 Asia Pacific: Analytical Testing Services Market, By Type, 2016–2023 (USD Million)
Table 164 Asia Pacific: CRO Services Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 165 Asia Pacific: CRO Services Market, By End User, 2016–2023 (USD Million)
Table 166 Total Number of Clinical Trials in China, By Therapeutic Area, 2017
Table 167 China: CRO Services Market, By Type, 2016–2023 (USD Million)
Table 168 China: Early-Phase Development Services Market, By Type, 2016–2023 (USD Million)
Table 169 China: Preclinical Services Market, By Type, 2016–2023 (USD Million)
Table 170 China: Clinical Research Services Market, By Type, 2016–2023 (USD Million)
Table 171 China: Laboratory Services Market, By Type, 2016–2023 (USD Million)
Table 172 China: Analytical Testing Services Market, By Type, 2016–2023 (USD Million)
Table 173 China: CRO Services Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 174 China: CRO Services Market, By End User, 2016–2023 (USD Million)
Table 175 Japan: CRO Services Market, By Type, 2016–2023 (USD Million)
Table 176 Japan: Early-Phase Development Services Market, By Type, 2016–2023 (USD Million)
Table 177 Japan: Preclinical Services Market, By Type, 2016–2023 (USD Million)
Table 178 Japan: Clinical Research Services Market, By Type, 2016–2023 (USD Million)
Table 179 Japan: Laboratory Services Market, By Type, 2016–2023 (USD Million)
Table 180 Japan: Analytical Testing Services Market, By Type, 2016–2023 (USD Million)
Table 181 Japan: CRO Services Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 182 Japan: CRO Services Market, By End User, 2016–2023 (USD Million)
Table 183 Total Number of Clinical Trials in India, By Therapeutic Area, 2017
Table 184 Increase in R&D Expenditure of Top 5 Indian Pharmaceutical Companies (2010 vs 2017)
Table 185 India: CRO Services Market, By Type, 2016–2023 (USD Million)
Table 186 India: Early-Phase Development Services Market, By Type, 2016–2023 (USD Million)
Table 187 India: Preclinical Services Market, By Type, 2016–2023 (USD Million)
Table 188 India: Clinical Research Services Market, By Type, 2016–2023 (USD Million)
Table 189 India: Laboratory Services Market, By Type, 2016–2023 (USD Million)
Table 190 India: Analytical Testing Services Market, By Type, 2016–2023 (USD Million)
Table 191 India: CRO Services Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 192 India: CRO Services Market, By End User, 2016–2023 (USD Million)
Table 193 Total Number of Clinical Trials in Australia, Singapore, & Malaysia, By Therapeutic Area, 2017
Table 194 RoAPAC: CRO Services Market, By Type, 2016–2023 (USD Million)
Table 195 RoAPAC: Early-Phase Development Services Market, By Type, 2016–2023 (USD Million)
Table 196 RoAPAC: Preclinical Services Market, By Type, 2016–2023 (USD Million)
Table 197 RoAPAC: Clinical Research Services Market, By Type, 2016–2023 (USD Million)
Table 198 RoAPAC: Laboratory Services Market, By Type, 2016–2023 (USD Million)
Table 199 RoAPAC: Analytical Testing Services Market, By Type, 2016–2023 (USD Million)
Table 200 RoAPAC: CRO Services Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 201 RoAPAC: CRO Services Market, By End User, 2016–2023 (USD Million)
Table 202 Total Number of Clinical Trials in Latin America, By Therapeutic Area, 2017
Table 203 Latin America: CRO Services Market, By Type, 2016–2023 (USD Million)
Table 204 Latin America: Early-Phase Development Services Market, By Type, 2016–2023 (USD Million)
Table 205 Latin America: Preclinical Services Market, By Type, 2016–2023 (USD Million)
Table 206 Latin America: Clinical Research Services Market, By Type, 2016–2023 (USD Million)
Table 207 Latin America: Laboratory Services Market, By Type, 2016–2023 (USD Million)
Table 208 Latin America: Analytical Testing Services Market, By Type, 2016–2023 (USD Million)
Table 209 Latin America: CRO Services Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 210 Latin America: CRO Services Market, By End User, 2016–2023 (USD Million)
Table 211 Total Number of Clinical Trials in the Middle East and Africa, By Therapeutic Area, 2017
Table 212 Middle East and Africa: CRO Services Market, By Type, 2016–2023 (USD Million)
Table 213 Middle East and Africa: Early-Phase Development Services Market, By Type, 2016–2023 (USD Million)
Table 214 Middle East and Africa: Preclinical Services Market, By Type, 2016–2023 (USD Million)
Table 215 Middle East and Africa: Clinical Research Services Market, By Type, 2016–2023 (USD Million)
Table 216 Middle East and Africa: Laboratory Services Market, By Type, 2016–2023 (USD Million)
Table 217 Middle East and Africa: Analytical Testing Services Market, By Type, 2016–2023 (USD Million)
Table 218 Middle East and Africa: CRO Services Market, By Therapeutic Area, 2016–2023 (USD Million)
Table 219 Middle East and Africa: CRO Services Market, By End User, 2016–2023 (USD Million)
Table 220 Growth Strategy Matrix (2014–2017)
 
 
List of Figures (46 Figures)
 
Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Data Triangulation Methodology
Figure 4 CRO Services Market, By Type, 2018 vs 2023 (USD Billion)
Figure 5 CRO Services Market, By Therapeutic Area, 2018 vs 2023 (USD Billion)
Figure 6 CRO Services Market, By End User, 2018 vs 2023 (USD Billion)
Figure 7 Geographic Snapshot: CRO Services Market
Figure 8 Growing R&D Expenditure and Increase in Number of Clinical Trials to Drive Market Growth During the Forecast Period
Figure 9 Phase Iii Segment Will Continue to Dominate APAC Clinical Research Services Market During the Forecast Period
Figure 10 The US Dominated the CRO Services Market in 2017
Figure 11 North America to Dominate the CRO Services Market During the Forecast Period
Figure 12 China to Register the Highest Growth During the Forecast Period
Figure 13 Contract Research Organization (CRO) Services Market: Drivers, Opportunities, and Challenges
Figure 14 Number of New Chemical Or Biological Entities (1997–2016)
Figure 15 Total Number of Registered Studies (2005–2017)
Figure 16 Total Number of New Molecular Entity (NME) and New Biologic License Application (BLA) Filings and Approvals in the US, 2006–2015
Figure 17 Key Trends in the CRO Services Market
Figure 18 Clinical Research Services Segment Will Continue to Dominate the Global CRO Services Market By 2023
Figure 19 Comparative Analysis of Clinical Trials Over the Years (2010–2016)
Figure 20 Biopharmaceutical Drugs Under Development, By Therapeutic Area, 2016
Figure 21 Phases of Drug Discovery Studies
Figure 22 Oncology Segment Will Continue to Dominate the Global CRO Services Market By 2023
Figure 23 Worldwide Cancer Incidence and Mortality (2012–2025)
Figure 24 Total Number of Clinical Trials for Oncology (2017)
Figure 25 Diabetes Prevalence, By Country, 2015 (Million Individuals)
Figure 26 Pharmaceutical & Biopharmaceutical Companies Segment to Dominate the CRO Services Market During the Forecast Period
Figure 27 R&D Spending of Phrma Member Companies, 1980–2015
Figure 28 Clinical Studies for Medical Devices (2017)
Figure 29 CRO Services Market: Geographic Growth Opportunities
Figure 30 Total Number of Clinical Trials: Global vs North America (2017)
Figure 31 North America: Market Snapshot
Figure 32 Pharmaceutical R&D Expenditure in the US (1990–2014)
Figure 33 Europe: Market Snapshot
Figure 34 Asia Pacific: Market Snapshot
Figure 35 Key Developments in the CRO Services Market, 2014–2017
Figure 36 Global CRO Services Market Share, By Key Player, 2017
Figure 37 IQVIA: Company Snapshot
Figure 38 LabCorp: Company Snapshot
Figure 39 PAREXEL: Company Snapshot
Figure 40 PRA Health Sciences: Company Snapshot
Figure 41 ICON PLC: Company Snapshot
Figure 42 Inc Research Holdings: Company Snapshot
Figure 43 WuXi Pharmatech: Company Snapshot
Figure 44 Charles River: Company Snapshot (2016)
Figure 45 Medpace Holdings: Company Snapshot
Figure 46 SGS: Company Snapshot

The global contract research organization services market is projected to reach USD 56.34 Billion by 2023 from USD 39.13 Billion in 2018, at a CAGR of 7.6%. Market growth can be attributed to the growing R&D expenditure, increased outsourcing of R&D activities, and increasing number of clinical trials.

The report analyzes the global CRO services market, by type, therapeutica area, end user, and region. Based on type, clinical research services accounted for the largest share of global CRO services market in 2017. This can be attributed to rapid growth in the geriatric population and the subsequent increase in the prevalence of chronic diseases, increasing development of new drugs, and growing acceptance of evidence-based medicine for various therapeutic areas.

Based on therapeutic area, oncology accounted for the largest share of the global CRO services market in 2017. The large share of this segment can be attributed to the increasing number of clinical trials and rising prevalence of cancer worldwide.

The global CRO services market, by end user, is segmented into pharmaceutical and biopharmaceutical companies, medical device companies, and academic institutes. In 2017, the pharmaceutical and biopharmaceutical companies segment accounted for the largest share of the contract research organization services market. The large share of this segment can be attributed to the increased outsourcing of early phase development services and clinical and laboratory testing services by pharmaceutical companies to boost profit margins, avoid high capital expenditure, and reduce the time duration to validate the process and product.

Geographically, the global CRO services market has been segmented into five major regional segments North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2017, North America accounted for the largest share of the CRO services market in 2017, followed by Europe and Asia Pacific. North America’s leading position in contract research organization services market is primarily attributed to the high-quality standards in the pharmaceutical industry, rapid growth in its biosimilars and biologics market, and increase in clinical trial activity.

The global pharmaceutical, biotechnology, and medical device R&D outsourcing industry is constantly evolving. Highly skilled professionals have to keep pace with the continuing changes in pharmaceutical and medical device R&D technologies and methodologies. CROs face challenges in attracting and retaining highly skilled professionals as they compete with pharmaceutical, biotechnology, medical device, and academic and research institutions for qualified and experienced scientists. To compete effectively, companies have to offer higher compensations and other benefits; this may affect the finances and results of operations of players, especially small-scale analytical testing providers. This shortage of skilled professionals may hamper the adoption of new technologies and methodologies, and inhibit the growth of the CRO services market in the coming years.

The prominent players in the global CRO services market are IQVIA (US), LabCorp (US), PAREXEL (US), PRA Health Sciences (US), PPD (US), ICON plc (Ireland), Syneos Health (US), Charles River (US), WuXi PharmaTech (China), SGS (Switzerland), Envigo (UK), and MPI Research (US).

IQVIA dominates the CRO services market, led by its strong performance in the biopharmaceutical services industry with wide geographical coverage. The company’s foothold in the market is primarily attributed to various factors such as strong technical and service capabilities, good client relationships, diversified service offerings, and its ability to expand the penetration of its offerings to a broad range. The company has registered significant growth in the biopharmaceutical services industry, and has a presence in all major markets, including the US, Japan, Germany, France, Spain, and Italy, in addition to Brazil, Russia, India, and China (BRIC countries). To increase its geographic presence and customer base, the company focused on expansion as a key growth strategy. Over the past three years, the company has made three major expansions. Moreover, IQVIA also focused on mergers and acquisitions to enhance and strengthen its position in the global contract research organization services market.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst